Your browser doesn't support javascript.
loading
Quality of Life of Patients with Head and Neck Cancer Receiving Cetuximab, Fluorouracil, Cisplatin Comparing to Cetuximab, Fluorouracil, Cisplatin, and Docetaxel within the CEFCID Trial.
Goerling, Ute; Gauler, Thomas; Dietz, Andreas; Grünwald, Viktor; Knipping, Stephan; Guntinas-Lichius, Orlando; Frickhofen, Norbert; Lindeman, Hans-Walter; Fietkau, Rainer; Haxel, Boris; Große-Thie, Christina; Maschmeyer, Georg; Zipfel, Matthias; Martus, Peter; Knoedler, Maren; Keilholz, Ulrich; Klinghammer, Konrad.
Afiliación
  • Goerling U; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Charité Comprehensive Cancer Center, Berlin, Germany.
  • Gauler T; Department of Radiation Oncology, West German Cancer Center, University of Duisburg-Essen Medical School, Essen, Germany.
  • Dietz A; Department of Otolaryngology, Head and Neck Surgery, University Leipzig, Leipzig, Germany.
  • Grünwald V; Interdisciplinary Urooncology, West German Cancer Center, Clinic for Internal Medicine (Tumor Research) and Clinic for Urology, University of Duisburg-Essen Medical School, Essen, Germany.
  • Knipping S; Department of Head and Neck Surgery, Dessau Medical Center, Dessau-Roßlau, Germany.
  • Guntinas-Lichius O; Department of Otorhinolaryngology, Jena University Hospital, Jena, Germany.
  • Frickhofen N; Department of Hematology & Oncology and Palliative Care, HELIOS Dr Horst Schmidt Kliniken Wiesbaden, Wiesbaden, Germany.
  • Lindeman HW; Department of Hematology & Oncology, KKH Hagen, Hagen, Germany.
  • Fietkau R; Department of Radiation Oncology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
  • Haxel B; Department of Otolaryngology, Head and Neck Surgery, Schwarzwald-Baar Klinikum, Villingen-Schwenningen, Germany.
  • Große-Thie C; Department of Otolaryngology, Head and Neck Surgery, University Medical Center of the Johannes Gutenberg University, Mainz, Germany.
  • Maschmeyer G; Department of Medicine, Clinic III - Hematology, Oncology, Palliative Medicine, Rostock University Medical Center, Rostock, Germany.
  • Zipfel M; Department of Hematology, Oncology and Palliative Care, Klinikum Ernst von Bergmann, Potsdam, Germany.
  • Martus P; Department of Internal Medicine III, University Hospital Bonn, Bonn, Germany.
  • Knoedler M; Institute for Clinical Epidemiology and Applied Biometry, University of Tuebingen, Tuebingen, Germany.
  • Keilholz U; University Cancer Center Leipzig, University Leipzig, Leipzig, Germany.
  • Klinghammer K; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Charité Comprehensive Cancer Center, Berlin, Germany.
Oncol Res Treat ; 45(6): 319-325, 2022.
Article en En | MEDLINE | ID: mdl-34915492
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Cisplatino / Neoplasias de Cabeza y Cuello Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Oncol Res Treat Año: 2022 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Cisplatino / Neoplasias de Cabeza y Cuello Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Oncol Res Treat Año: 2022 Tipo del documento: Article País de afiliación: Alemania